Patent Classification

Drug Delivery System, Oral Rinse/Cleansing/Care

1. Use of ozone for the treatment of bad breath
    
2. Composition and process for indicating the presence of soluble fluoride ion in oral care compositions and method of making the same
    
3. Method of controlling release of antimicrobial agents in chewing gum
    
4. Fast dissolving orally consumable films
    
5. Gelatin soft capsule having the properties of removal of oral smell and cleaning of oral cavity
    
6. Composition and method for promoting oral health
    
7. Composition and method for inhibiting oral bacteria
    
   
8. Oral care composition
    
9. Stable hydrogenated lupulone antibacterial oral compositions
    
   
10. Oral care composition
     
    
11. Oral cleansing: methods and compositions
     
    
12. Stable zinc/citrate/CPC oral rinse formulations

Drug Delivery System, Osmotic/Hydrostatic Delivery System

1. Hydrostatic delivery system for controlled delivery of agent
    
2. Expandable osmotic composition and coating suspension
    
3. Osmotic device containing venlafaxine and an anti-psychotic agent
    
4. Osmotic drug delivery system
    
5. Oral osmotic controlled drug delivery system for a sparingly soluble drug
    
6. Soluble form osmotic dose delivery system
    
7. Soluble form osmotic dose delivery system
   
   
8. Combined diffusion/osmotic pumping drug delivery system
   
   
9. Osmotic medicament releasing system
    
   
10. Soluble form osmotic dose delivery system
     
    
11. Osmotic delivery composition, solution, and method
     
    
12. Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents
     
    
13. Osmotic drug delivery system

Drug Delivery System, Other

1. Formulations and methods for providing prolonged local anesthesia
    
   
2. Hydrophilic binary systems for the administration of lipophilic compounds

Drug Delivery System, Packaging

1. Moisture resistant container systems for rapidly bioavailable dosage forms
    
2. Moisture resistant container systems for rapidly bioavailable dosage forms
    
3. Medicinal product package for eradication therapy
    
4. Blister package for pharmaceutical treatment card
    
5. Preparation consisting of a film, sheet or wafer-shaped form of administration with a two-layered structure and an integrated identification marking
    
6. Packaged ophthalmic perfusate and cleaning fluid bag
    
7. Antioxidant enriched adhesive compositions and storage containers therefor
    
8. Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone
    
9. Packaged markable ingestible compressible object
    
10. Strip pack
    
    
11. Dividable tablet and press-through pack 
    
    
12. Method and apparatus for the interim storage of medicated oral dosage forms
     
    
13. Package and packaging method for aqueous liquid materials
     
    
14. Container with freeze-dried vaccine components
     
    
15. Preparation consisting of a surface-adhering, film-like or wafer-like administration form
     
    
16. Blister pack arrangement
     
    
17. Childproof package for active substance patches
     
    
18. Container for ascorbic acid composition

Drug Delivery System, Parenteral/Intrathecal/Peritoneal

1. Stabilized synthetic immunogen delivery system
    
2. Naltrexone long acting formulations and methods of use
    
3. Intravenous delivery of polynucleotides to cells in mammalian limb
    
4. Multi-part substitution infusion fluids and matching anticoagulants
    
5. Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and hydrogels thus obtained
    
6. Methods for the formulation and manufacture of artesunic acid for injection
    
7. Injection vehicle for polymer-based formulations
    
8. Dimethicone-containing sustained release injection formulation
    
9. Long acting injectable insulin composition and methods of making and using thereof
    
10. Pharmaceutical formulation comprising ziconotide
     
11. Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances
     
12. Injectable compositions for the controlled delivery of pharmacologically active compound
     
13. Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
     
14. Compositions for parenteral administration and sustained-release of therapeutic agents
     
15. Sodium bicarbonate/sodium chloride micronized slurry
     
16. Antifungal parenteral products
     
17. Multi-part substitution infusion fluids and matching anticoagulants
     
18. Injectable system for controlled drug delivery
     
19. Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds
     
20. Non-aqueous injectable formulations for extended release of somatotropin
     
21. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
     
22. Injectable compositions for the controlled delivery of pharmacologically active compound
     
23. Biochemically balanced peritoneal dialysis solutions
     
24. Stability for injection solutions
     
25. Antifungal parenteral products
     
26. Testosterone derivative
     
27. Prolonged release microspheres for injectable administration
     
28. Pharmaceutical composition comprising factor VIII and neutral liposomes
     
29. Method for preparing a calcium phosphate pasty material for injection
     
30. Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
     
31. Stabilized difloxacin injectable solution
     
32. Enteral formulation
     
33. Formulation for the parenteral application of a sodium channel blocker
     
34. Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
     
35. Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
     
36. Freeze-dried pantoprazole preparation and pantoprazole injection
     
37. Catheter flush solution and method for its use
     
38. Substitution infusion fluid and citrate anticoagulation
     
39. Emulsion stability
     
40. Injectable hyaluronic acid derivative with pharmaceuticals/cells
     
41. Starch microparticles
     
42. Pharmaceutically acceptable starch
     
43. Method of preparing a solution, in particular a dialysis or infusion solution
     
44. Stable particle in liquid formulationsStable particle in liquid formulations
     
45. Preparation of injectable suspensions having improved injectability
     
46. Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
     
47. Stability for injection solutions
     
48. Concentrated injection and infusion solution for intravenous administration
     
49. Method for inducing therapeutically-effective proteins
     
50. Stability for injection solutions
     
51. Parenteral Cisplatin emulsion
     
52. Lyophilizate of lipid complex of water insoluble camptothecins
     
53. Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
     
54. Injectable pharmaceutical composition comprising coated particles of camptothecin
     
55. Stabilized aqueous suspensions for parenteral use
     
56. Room temperature storable immunoglobulin preparation for intravenous injection
     
57. Prefilled, low particle, sterile disposable syringe for injecting preparations and procedure for manufacture
     
    
58. Injectable depot gel composition and method of preparing the composition
     
    
59. Method and device for producing a parenteral medicament
     
    
60. Clear, injectable formulation of an anesthetic compound
     
    
61. Cylinder ampoule
     
    
62. Finger brace for hypodermic syringe
     
    
63. Prefilled ampoules and manufacture thereof
     
    
64. Injectable hyaluronate-sulfated polysaccharide conjugates
     
    
65. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
     
    
66. Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
     
    
67. Infusion pump with an electronically loadable drug library and a user interface for loading the library
     
    
68. Needleless injector drug capsule and filling method
     
    
69. Drug delivery compositions suitable for intravenous injection
     
    
70. Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
     
    
71. Needleless syringe
     
    
72. Stable calcitriol solution for packaging into vials
     
    
73. Aqueous solution of t-PA
     
    
74. Auto-injection device
     
    
75. Injectable bio-active glass in a dextran suspension
     
    
76. Composition and method for stable injectable liquids
     
    
77. Stabilized insulin compositions
     
    
78. Injection viral treatment
     
    
79. Parenteral water-miscible non intensely colored injectable composition of non-steroidal anti-inflammatory drugs
     
    
80. Peritoneal dialysis solution
     
    
81. Injectable formulations of nanoparticulate naproxen
     
    
82. Stable mitoxantrone solutions
     
    
83. Injectable composition
     
    
84. Propofol composition
     
    
85. Injectable hydrogel compositions
     
    
86. Container filled with infusion liquids and infusion preparation
     
    
87. Intravenous form of thalidomide for treating immunological diseases
     
    
88. Methods for universally distributing therapeutic agents to the brain
     
    
89. Stable intravenously-administrable immune globulin preparation
     
    
90. Needle-less parenteral introduction device
     
    
91. Methods and compositions useful for administration of chemotherapeutic agents
     
    
92. Pharmaceutical injection solution containing taxol
     
    
93. Administration of an injectable antibiotic in the ear of an animal
     
    
94. Injectable chondrocyte-carrier suspension for treatment of vesicoureteral reflux and incontinence
     
    
95. Long acting injectable parasiticidal composition and the process for its preparation
     
    
96. Parenteral metolazone formulations
     
    
97. Parenteral pimaricin as treatment of systemic infections
     
    
98. Stable liquid paracetamol compositions, and method for preparing same
     
    
99. Stable prostaglandin E1-containing injectable composition
     
    
100. Pharmaceutical composition containing cyclosporin A
      
     
101. Stable aqueous solution having high concentrations of calcium and phosphate ions and solid complex
      
     
102. Stabilized pharmaceutical compositions containing dobutamine
      
     
103. Crystalline protein controlled release compositions
      
     
104. Compositions and method for treating migraine
      
     
105. Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation
      
     
106. Nonaqueous compositions for parenteral administration

Drug Delivery System, Pediatric

1. Pediatric formulation of gatifloxacin
    
2. Pediatric method of use of bambuterol

Drug Delivery System, Pellet/Bolus

1. Continuous melt spheronization apparatus and process for the production of pharmaceutical pellets
    
2. Drug carrier pellet production process
    
3. Controlled absorption diltiazem pharmaceutical formulation
    
4. Pellets and process for production thereof
    
5. Controlled release oral dosage form
    
6. Rapidly decomposing chitosan-based pellets
    
7. Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
    
8. Systems and methods for local delivery of an agent
    
   
9. Fast decomposing pellets
    
   
10. Pharmaceutical delivery device and method of preparation therefor
     
    
11. System and methods for local delivery of an agent
     
    
12. Inhalation composition containing lactose pellets
     
    
13. Orally administrable nifedipine pellet and process for the preparation thereof
     
    
14. Pharmaceutical pellet formulation
     
    
15. Omeprazole formulation
     
    
16. System and methods for local delivery of an agent
     
    
17. Controlled absorption diltiazem pharmaceutical formulation
     
    
18. Pellet for administration to ruminants

Drug Delivery System, Peptide/Protein/Nucleic Acid

1. Nanoparticles for protein/peptide delivery and delivery means thereof
    
2. Stabilized preparations of serine endopeptidases, their preparation and use
    
3. Fast-acting oral peptide pharmaceutical products
    
4. Polymeric carrier for delivery of small interfering RNA
    
5. Transmembrane delivery peptide and bio-material comprising the same
    
6. Concentrated protein lyophilates, methods, and uses
    
7. Method for stabilization of proteins in solution
    
8. Pharmaceutical compositions and methods for peptide treatment
    
9. Stabilized liquid polypeptide-containing pharmaceutical compositions
    
10. Intravenous delivery of polynucleotides to cells in mammalian limb
     
11. Methods for increasing protein polyethylene glycol (PEG) conjugation
     
12. Immunoglobulin fusion proteins
     
13. Method for stabilization of proteins in solution
     
14. Stable polypeptide formulations
     
15. Plasma cryoprecipitate substantially free of plasminogen
     
16. Zinc-containing sustained-release composition, its preparation, and method for producing the same
     
17. Nanoparticles for protein drug delivery
     
18. Reducing the immunogenicity of fusion proteins
     
19. Stable protein storage and stable nucleic acid storage in recoverable form
     
20. Binding compounds specific for cysteine-rich soluble protein C23
     
21. Nanoparticles for protein drug delivery
     
22. Stoichiometric conjugates of biocompatible polymers at the unpaired cysteine residue of the wild-type G-CSF
     
23. Nanoparticles for protein drug delivery
     
24. Intravascular delivery of nucleic acid
     
25. Microparticles with adsorbed polypeptide-containing molecules
     
26. Protein and peptide delivery to mammalian cells in vitro
     
27. Nanoparticles for protein/peptide delivery and delivery means
     
28. Dendritic encapsulation of active agents
     
29. Stabilized soluble glycoprotein trimers
     
30. Cosmetic or pharmaceutical composition containing peptides
     
31. Intravascular delivery of nucleic acid
     
32. Stabilized protein crystals, formulations comprising them and methods of making them
     
33. Hydrophobic biomolecular structure
     
34. Stable lipid-comprising drug delivery complexes and methods for their production
     
35. Peptides and medicinal compositions containing the same
     
36. Sustained release formulation
     
37. Formulations for amylin agonist peptides
     
38. Nanoparticles for protein drug delivery
     
39. Nucleic acid-containing complex
     
40. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
     
41. Method for determining release of a peptide from a sustained release polylactide formulation
     
42. Methods of delivering aerosolized polynucleotides to the respiratory tract
     
43. Peptides as solubilizing excipients for transforming growth factor beta proteins
     
44. Nuclear targeting by means of bacterial proteins
     
45. Long-term stabilized formulations
     
46. Stabilization of pharmaceutical protein formulations with small peptides
     
47. Compositions and methods for drug delivery using pH sensitive molecules
     
48. Method for directed packaging of molecular substances in protein shells
     
49. Micellar systems
     
50. Stabilized proteins
     
51. Controlled nucleic acid delivery systems
     
52. Process of making a compound by forming a polymer from a template drug
     
53. Aquespheres, their preparation and uses thereof
     
54. Povidone-containing carriers for polypeptide growth factors
     
55. Reducing the immunogenicity of fusion proteins
     
56. Stabilization of cardiac troponin I subunits and complexes
     
57. Polyol/oil suspensions for the sustained release of proteins
     
58. Interferon and albumin fusion protein
     
59. Stable spray-dried protein formulations
     
60. N-terminally chemically modified protein compositions and methods
     
61. Slow release protein polymers
     
62. Methods and compositions for enhancing the delivery of a nucleic acid to a cell
     
63. Compositions and methods for drug delivery using pH sensitive molecules
     
64. Polynucleotide complex delivery
     
65. Proteins stabilized with polysaccharide gums
     
66. Particle delivery techniques
     
67. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues
     
68. Formation of polyampholytes in the presence of a polyion
     
69. Reduced-viscosity concentrated protein formulations
     
70. Compositions and methods for topical delivery of oligonucleotides
     
71. Stabilizer for pharmacons
     
72. Protein formulation
     
73. Polyampholytes for delivering polyions to a cell
     
74. Compositions for inhalation
     
75. Solid preparations for oral administration of drugs relating to genes
     
76. Granule containing enzyme, corn starch and sugar layered on an inert particle
     
77. Methods for quantitative analysis of nucleic acid amplification reaction
     
78. Sequence and method for genetic engineering of proteins with cell membrane translocating activity
     
79. Method for targeted delivery of nucleic acids
     
80. Process for producing composite preparation containing nucleic acid
     
81. Compositions and methods for drug delivery using amphiphile binding molecules
     
82. Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents
     
83. Sublingual compositions comprising thymosin fraction 5 and methods for administration thereof
     
84. Methods for encapsulating nucleic acids in lipid bilayers
     
85. Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
     
86. Slow release protein polymers
     
87. Poliovirus replicons encoding therapeutic agents and uses thereof
     
88. Oral delivery of peptides using enzyme-cleavable membrane translocators
     
89. Compositions for inhalation
     
90. Self-assembling colloidal carriers for protein delivery
     
91. Delivery of biologically active polypeptides
     
92. Stabilizing diluent for polypeptides and antigens
     
93. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
     
94. Site protected protein modification
     
95. Process for producing composite preparation containing nucleic acid
     
96. Stabilized protein crystals formulations containing them and methods of making them
     
97. Aerosol formulations of peptides and proteins
     
98. Stabilized liquid polypeptide-containing pharmaceutical compositions
     
99. Pharmaceutical compositions for prolonged peptide release and preparation method
     
100. Temperature sensitive gel for sustained delivery of protein drugs
      
101. Pharmaceutical compositions comprised of stabilized peptide particles
      
102. Reverse micelles for delivery of nucleic acids
      
103. Granule containing protein and salt layered on an inert particle
      
104. Protein occlusion for delivery of small molecules
     
     
105. Process for fractionating polyethylene glycol (PEG) --protein adducts and an adduct of PEG and granulocyt-macrophage colony stimulating factor
     
     
106. Intravascular delivery of non-viral nucleic acid
     
     
107. Process of making a compound by forming a polymer from a template drug
      
     
108. Sustained GnRH peptide-release formulation
      
109. Method of enhancing the delivery of nucleic acids using silica nanoparticles
      
     
110. Delivery of nucleic acid materials
      
     
111. Compositions and methods for nucleic acid delivery to the lung
      
     
112. Transforming growth factor .beta. crystals
      
     
113. Peptide/lipid complex formation by co-lyophilization
      
     
114. Methods and compositions for peptide synthesis
      
     
115. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
      
     
116. Process for stabilizing proteins
      
     
117. Method to detect proteins
      
     
118. Proteinic drug delivery system using membrane mimetics
      
     
119. Controlled release delivery of peptide or protein
      
     
120. Synthetic peptides and vaccines comprising same
      
     
121. Synthesis of polymer bio-active conjugates
      
     
122. Stabilizing solutions for proteins and peptides
      
     
123. Use of locally applied DNA fragments
      
     
124. Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria
      
     
125. Process of making a compound by forming a polymer from a template drug
      
     
126. Non-aqueous polar aprotic peptide formulations
      
     
127. Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
      
     
128. Peptide copolymer compositions
      
     
129. Oral peptide pharmaceutical products
      
     
130. Process to manufacture implants containing bioactive peptides
      
     
131. Liposomal transfection method
      
132. Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
      
     
133. Stabilized conjugates of uncomplexed subunits of multimeric proteins
      
     
134. Aqueous formulations of peptides
      
     
135. Preparation of protein microparticles by supercritical fluid precipitation
      
     
136. PVA or PEG conjugates of peptides for epitope-specific immunosuppression
      
     
137. Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
      
     
138. Chemical modification of repetitive polymers to enhance water solubility
      
     
139. Stable preparation for the treatment of blood coagulation disorders
      
     
140. Method of protein therapy by orally administering crosslinked protein crystals
      
     
141. Sustained-release protein formulations
      
     
142. Peptide formulation
      
     
143. Intravaginal preparation containing physiologically active peptide
      
     
144. Crystalline protein controlled release compositions
      
     
145. Powder formulations containing melezitose as a diluent
      
     
146. Method and compositions for solubilization and stabilization of polypeptides, especially proteins
      
     
147. Peptide/protein suspending formulations

Drug Delivery System, Personal Care/OTC Products

1. Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
    
2. Personal care article with distinct active zone
    
3. Lactic acid producing bacteria for use as probiotic organisms in the human vagina
    
4. High efficacy gel with low glycol content
    
5. Use of ozone for the treatment of bad breath
    
6. Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting
    
7. Sweet with a rough texture intended for the treatment of halitosis
    
8. Method to produce a tampon that inhibits exoprotein production from gram positive bacteria
    
9. Methods for preparing pharmaceutical formulations
    
10. Gelatin soft capsule having the properties of removal of oral smell and cleaning of oral cavity
     
11. Emulsification systems and emulsions
     
12. Dentrifice comprising calcium carbonate granules
     
13. Method of disinfecting contact lens and disinfecting liquid for the method
     
14. Ambroxol-containing lozenge
     
15. Inhibition of exoprotein production from gram positive bacteria
     
16. Method of reducing eye irritation
     
17. Engineered polypeptides in personal care applications
     
18. Compositions and methods for treating eye discomfort
     
19. Antiviral compositions for tissue paper
     
20. Use of fats to replace silicone in cosmetic and/or pharmaceutical preparations
     
21. Low temperature process for making stable anhydrous solutions of antiperspirant active in selected 1,2-diol solvents
     
22. Method for preparing ultraviolet radiation-absorbing compositions
    
    
23. Antiperspirant actives from a glass form and products made therewith 
    
    
24. Methods for quantitating the efficacy of oral care products
     
    
25. Thickened aqueous surfactant solutions
     
    
26. Thermochromic flowable topical personal care product
     
    
27. Use of silica as agent for controlling the degradation of bicarbonate, resulting mixture and its application
     
    
28. Silicone solvents for antiperspirant salts
     
    
29. Non-spherical and non-platelet forms of pyrithione salts and methods of making same
     
    
30. Diaper with osmotic pressure control
     
    
31. Chemical linker compositions
     
    
32.  Non-irritating composition for treating acne and other skin conditions
     
    
33. Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
     
    
34. Fluidized polymer suspensions of cationic polysaccharides in polyols and use thereof in personal care compositions

Drug Delivery System, Pouch

1. Digestible pouch and method for administering medications to an animal

Drug Delivery System, Powder

1. Solubilizing aids in powder form for solid pharmaceutical presentation forms
    
2. Powdery preparation for nasal administration
    
3. Phospholipid-based powders for drug delivery
    
4. Storage stable powder compositions of interleukin-4 receptor
    
5. Pharmaceutical formulation comprising amoxycillin and clavulanate
    
6. Process for preparing powder formulations
    
7. Water soluble powders and tablets
    
8. Storage stable powder compositions of interleukin-4 receptor
    
9. Particle delivery techniques
    
10. Powder Composition for nasal administration
     
11. Anti-fungal powder having enhanced excipient properties
     
12. Method of manufacturing powder particles
     
13. Powdery nasal compositions
     
14. Powder compositions comprising a skin irritation reducing agent
     
15. Clump-free liquid dispersible powder compositions and process for making the same
    
    
16. Powdered pharmaceutical formulations having improved dispersibility
     
    
17. Medical powder
     
    
18. Powdered pharmaceutical formulations having improved dispersibility
     
19. Powder compositions
     
    
20. Powders for inhalation
     
    
21. Method for producing powder formulation comprising an insulin
     
    
22. Free-flowing dry particles
     
    
23. Compositions and methods for nucleic acid delivery to the lung
     
    
24. Water soluble powder form compositions and their applications thereof
     
    
25. Controlled release insufflation carrier for medicaments

Drug Delivery System, Preservative

1. Preserved pharmaceutical formulations
    
2. Preserved pharmaceutical formulations
    
3. Preserved pharmaceutical compositions comprising cyclodextrins
    
4. Use of lacrophyl preparation in eye drops containing therapeutically active compounds
    
5. Preserved cyclodextrin-containing compositions
   
   
6. Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
    
   
7. Preserving system and its use in a cosmetic or pharmaceutical composition

Drug Delivery System, Prodrug

1. Prodrug of an ICE inhibitor
    
2. Activation of peptide prodrugs by hK2
    
3. Use of specifically engineered enzymes to enhance the efficacy of prodrugs
    
4. Abuse-resistant amphetamine prodrugs
    
5. Abuse-resistant amphetamine prodrugs
    
6. Heparin prodrugs and drug delivery stents formed therefrom
    
7. Prodrugs of pharmaceuticals with improved bioavailability
    
8. Tissue specific prodrugs
    
9. Nonporous microparticle-prodrug conjugates for treatment of infection
    
10. Use of specifically engineered enzymes to enhance the efficacy of prodrugs
     
11. Heparin prodrugs and drug delivery stents formed therefrom
     
12. Water soluble paclitaxel prodrugs
     
13. Prodrugs of thrombin inhibitors
     
14. P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT)
     
15. Fusion proteins for prodrug activation
     
16. Prodrug compositions and drug delivery methods using synthetic receptors
     
17. Anaerobe targeted enzyme-mediated prodrug therapy
     
18. Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
     
19. Vector for expression of GPI-enzyme hybrid
     
20. Mutual prodrug of amlodipine and atorvastatin
     
21. Method of targeting pharmaceuticals to motor neurons
     
22. Selenium-containing pro-drugs for cancer therapy
     
23. Stabilized thyroxine compounds
     
24. Medical use of gene and vector encoding a multisubstrate deoxyribonucleoside kinase
     
25. Anaerobe targeted enzyme-mediated prodrug therapy
     
26. Sensitizing cells to compounds using lipid-mediated gene and compound delivery
    
    
27. Prodrugs with enhanced penetration into cells
    
    
28. Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
     
    
29. Self-assembled taxo-diterpenoid nanostructures
     
    
30. Water soluble paclitaxel prodrugs
     
    
31. Prodrugs activated by targeted catalytic proteins
     
    
32. Prodrugs with enhanced penetration into cells
     
    
33. Prodrugs, their preparation and use as pharmaceuticals
     
    
34. Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof
     
    
35. Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
     
    
36. Prodrugs of proton pump inhibitors
     
    
37. Prodrugs comprising fluorinated amphiphiles
     
    
38. Surface expression of enzyme in gene directed prodrug therapy
     
    
39. Prodrugs with enhanced penetration into cells
     
    
40. Prodrugs their preparation and use as pharmaceuticals

Drug Delivery System, Quick Dissolving

1. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
    
2. Stable foam composition
    
   
3. Rapidly dissolving robust dosage form
    
   
4. Delivery of controlled-release system(s)

Drug Delivery System, Radiation Guided

1. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
    
2. X-ray guided drug delivery

Drug Delivery System, Radical, Free

1. Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates

Drug Delivery System, Resistance, Abuse

1. Process for the production of an abuse-proofed solid dosage form
    
2. Opioid agonist/antagonist combinations

Drug Delivery System, Sachet

1. Sachet formulations

Drug Delivery System, Saline Solution

1. Hypoosmotic saline solutions, method for preparing same and medicines based on said solution

Drug Delivery System, Semi-Solid/Cream/Ointment

1. Use of octenidine dihydrochloride in semisolid preparations
    
2. Ophthalmic ointments for treating infective eye disease
    
3. Use of fats to replace silicone in cosmetic and/or pharmaceutical preparations
    
4. Aerosol ointment compositions for topical use
    
   
5. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
    
   
6. Spill resistant pharmaceutical compositions in semi-solid form

Drug Delivery System, Solid Solution/Dispersion

1. Solid dispersions comprising tacrolimus
    
2. Stabilised solid drug dispersions in an organic carrier and a process for preparing the same
    
3. Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
    
4. Rapidly disintegrable pharmaceutical composition
    
5. Pharmaceutical compositions for poorly soluble drugs
    
6. Solid dose delivery vehicle and methods of making same
    
7. Solid dispersion composition
    
8. Solid solution beadlet
    
9. Solid pharmaceutical dispersions
    
10. Aqueous process for manufacturing paroxetine solid dispersions
     
    
11. Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
     
    
12. Pharmaceutical compositions comprising rafamycin coprecipitates
     
    
13. Method of producing a solid dispersion of a poorly water soluble drug
     
    
14. Solid solution of an antifungal agent with enhanced bioavailability